Papers: 16 May 2016 - 23 May 2016

Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation.

Papers:

Editors' Pick

Estimating a treatment effect: Choosing between relative and absolute measures.

Sormani M P, Bruzzi P

Mult Scler. 2016 Apr 29. Epub 1969 Dec 31. PMID: 27207463. Abstract

Editors' Pick

The transcriptome of mouse central nervous system myelin.

Thakurela S, Garding A, Jung RB, Müller C, Goebbels S, White R, Werner HB, Tiwari VK

Sci Rep. 2016; 6:25828. Epub 1969 Dec 31. PMID: 27173133. Abstract

Risk of Relapse Among Propensity Score Matched Multiple Sclerosis Patients Receiving Natalizumab or Platform Therapy in the US.

Watson C, Bonafede MM, Johnson BH

Value Health. 2014 Nov; 17(7):A391. PMID: 27200903. Abstract

A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database.

Phillips AL, Munsell MJ, Menzin J, Dangond F, Locklear JC

Value Health. 2014 Nov; 17(7):A392. PMID: 27200906. Abstract

Evaluation of Disability Progression as an Endpoint in Clinical Trials for Relapsing-Remitting Multiple Sclerosis (RRMS): Comparison of the Define and Confirm Studies.

Viglietta V, O'Gorman J, Yang M, Zhang R, Raghupathi K

Value Health. 2014 Nov; 17(7):A392. PMID: 27200907. Abstract

Cost-Effectiveness of Subcutaneous Verse Intramuscular Interferon Beta-1A In Portugal Based on the Findings of Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.

Silverio N, Sequeira L, Meletiche D

Value Health. 2014 Nov; 17(7):A398. PMID: 27200940. Abstract

Modelling the Impact of Persistence Improvements with an Electronic Injection Device on Escalation to 2nd Line Treatment in Patients with Relapsing Remitting Multiple Sclerosis (RRMS).

Meletiche DM, Rutkowski T, Martin de Bustamante MA, Chowdhury CA, Beckerman R

Value Health. 2014 Nov; 17(7):A390. PMID: 27200899. Abstract

The Characteristics of Multiple Sclerosis in Iran.

Khanizadeh H, Nikkhah K, Izham M

Value Health. 2014 Nov; 17(7):A392-3. PMID: 27200910. Abstract

An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study.

Phillips AL, Edwards NC, Locklear JC

Value Health. 2014 Nov; 17(7):A397. PMID: 27200937. Abstract

Comparison of a Markov Cohort Model and a Discrete-Event Simulation for Economic Analyses of Treatments for Multiple Sclerosis.

Kansal A, Tafazzoli A, Leipold R, Sarda S

Value Health. 2014 Nov; 17(7):A398. PMID: 27200939. Abstract

Epidemiology of Multiple Sclerosis in Latin America: Critical Analysis of the Literature.

Einarson TR, Bereza B, Machado M

Value Health. 2014 Nov; 17(7):A393. PMID: 27200911. Abstract

Cost-Effectiveness of Subcutaneous Interferon Beta-1A in a Sub-Population of Multiple Sclerosis Patients (Kurtzke Expanded Disability Status Scale [EDSS]: >3.5-5.0).

Phillips AL, Edwards NC, Locklear JC

Value Health. 2014 Nov; 17(7):A398. PMID: 27200942. Abstract

Cost Analysis of the Use of Glatiramer Acetate Compared to Interferon-Â in Patients with Relapsing-Remitting Multiple Sclerosis and Spasticity in Spain.

Sanchez de la Rosa R, Garcia BL, Meca Lallana J

Value Health. 2014 Nov; 17(7):A394. PMID: 27200920. Abstract

The Long-Term Value of Glatiramer Acetate for the Treatment of Relapsing Remitting Multiple Sclerosis in the Netherlands.

Purchase JL, Wilson LE, Prüfert A

Value Health. 2014 Nov; 17(7):A398-9. PMID: 27200944. Abstract

Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.

Soini E, Asseburg C, Sumelahti ML

Value Health. 2014 Nov; 17(7):A399. PMID: 27200945. Abstract

Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis.

Li L, Shrestha S, Baser O, Wang L

Value Health. 2014 Nov; 17(7):A399. PMID: 27200946. Abstract

Psychometric Analyses to Inform Item Reduction and Evaluate Sensitivity of the Early Mobility Impairment Questionnaire for Multiple Sclerosis.

Phillips GA, Mathias A, Coon CD, Agarwal SS, Sen R, Shah R, Ziemssen T

Value Health. 2014 Nov; 17(7):A403. PMID: 27200970. Abstract

The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies.

Blackney M, Kelly M, Zeidman R, Andreykiv M, Plich A

Value Health. 2014 Nov; 17(7):A393. PMID: 27200915. Abstract

Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital Perspective.

Viriato D, Carrasco J, Fonseca J, Pacheco R

Value Health. 2014 Nov; 17(7):A393-4. PMID: 27200916. Abstract

Budget Impact Analysis of Fingolimod in Relapsing Remitting Multiple Sclerosis.

Ruggeri M, D'Ausilio A, Lo Muto R, Cottone S, Ghezzi A, Mecozzi A, Sacchini D, Mangone M

Value Health. 2014 Nov; 17(7):A393. PMID: 27200914. Abstract

Pharmacoeconomic Aspects of Multiple Sclerosis Treatments in Iran.

Khanizadeh H, Izham M, Nikkhah K

Value Health. 2014 Nov; 17(7):A395-6. PMID: 27200922. Abstract

Does Current Portuguese Financing Model for Multiple Sclerosis Covers for Estimated Needs?

Montóia B, Guerreiro T, Viana R

Value Health. 2014 Nov; 17(7):A395. PMID: 27200924. Abstract

Systematic Review of the Economics of Multiple Sclerosis in Latin America.

Einarson TR, Bereza B, Machado M

Value Health. 2014 Nov; 17(7):A394. PMID: 27200919. Abstract

Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.

Silverio N, Sequeira L, Meletiche D

Value Health. 2014 Nov; 17(7):A396. PMID: 27200931. Abstract

The Impact of Adherence and Development of Neutralizing Antibodies to Interferons β on Treatment of Multiple Sclerosis in the Czech Republic.

Kruntoradova K, Klimes J, Dolezal T, Mandelikova M, Pavlikova P

Value Health. 2014 Nov; 17(7):A397. PMID: 27200935. Abstract

Analysis of the Recent HTA Decision Making Landscape for Multiple Sclerosis Therapies - Trends and Future Opportunities.

Mardiguian S, Walsh SCM

Value Health. 2014 Nov; 17(7):A404. PMID: 27200971. Abstract

Comparing Characteristics of Hungarian "Real Life" Patients With Participants of RCTS: First-Line Disease Modifying Therapies in Multiple Sclerosis.

Foldesi C, Penzes M, Szabo M

Value Health. 2014 Nov; 17(7):A404. PMID: 27200972. Abstract

Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis.

Phillips AL, Kozma CM, Locklear JC

Value Health. 2014 Nov; 17(7):A400. PMID: 27200951. Abstract

Analysis of Expenditure in Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2013 in Spain.

Villoro R, Hidalgo A

Value Health. 2014 Nov; 17(7):A396. PMID: 27200933. Abstract

Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking Injectable and Oral Disease Modifying Treatments in the United States.

Narayanan S, O'Meara P, White J, Chan J, Gabriele S

Value Health. 2014 Nov; 17(7):A404-5. PMID: 27200973. Abstract

The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland.

Mocko P, Kawalec P

Value Health. 2014 Nov; 17(7):A528-9. PMID: 27201673. Abstract

Systematic Review and Critique of Health Economic Models on Relapsing-Remitting Multiple Sclerosis in the UK.

Kusel J, Maruszczak M, Montgomery S, Allen F, Adlard N

Value Health. 2014 Nov; 17(7):A548. PMID: 27201780. Abstract

Patterns of Use of Tests to Monitor Disease Activity Among Patients With Relapsing Remitting Multiple Sclerosis in the United States and Europe.

Narayanan S, O'Meara P, White J, Chan J, Gabriele S

Value Health. 2014 Nov; 17(7):A404. PMID: 27200975. Abstract

Persistence with Fingolimod Versus Dimethyl Fumarate in Patients with Multiple Sclerosis: Retrospective Analysis of us Open-Source Pharmacy Data.

Bergvall N, Lahoz R, Nazareth T, Korn JR

Value Health. 2014 Nov; 17(7):A400-1. PMID: 27200952. Abstract

Evaluating Working Ability and Quality of Life of Patients with Multiple Sclerosis.

Kreimendahl F, Rychlik RPT, Patel S, Gleissner E, Becker V

Value Health. 2014 Nov; 17(7):A403. PMID: 27200968. Abstract

Quality of Life Among Patients with Multiple Sclerosis Treated with Prolonged-Release Fampridine 10 Mg Tablets for Walking Impairment.

Liu Y, McNeill M, Lee A, Zhong J, Mehta LR

Value Health. 2014 Nov; 17(7):A401-2. PMID: 27200955. Abstract

Humanistic Research Outcomes in Multiple Sclerosis: Review of the Literature from Latin America.

Einarson TR, Bereza B, Machado M

Value Health. 2014 Nov; 17(7):A401. PMID: 27200957. Abstract

Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis.

Maruszczak M, Kusel J, Adlard N

Value Health. 2014 Nov; 17(7):A399. PMID: 27200949. Abstract

Modelling the Persistence of Disease-Modifying Drug Treatment (DMT) and its Independent Drivers in Finnish Multiple Sclerosis (MS) Patients: Parametric Survival Modelling.

Soini E, Holmberg M, Asseburg C, Sumelahti ML

Value Health. 2014 Nov; 17(7):A400. PMID: 27200954. Abstract

Working Ability and Monetarily Valued Productivity of Patients with Multiple Sclerosis Treated with Natalizumab.

Kreimendahl F, Rychlik RPT, Patel S, Gleissner E, Becker V

Value Health. 2014 Nov; 17(7):A400. PMID: 27200953. Abstract

Cognitive Impairment and Health Related Quality of Life in Relapsing Remitting Multiple Sclerosis.

Balaña M, Galera J, López-Góngora M, Escartín A, Izquierdo G, Borges M, Garcia E

Value Health. 2014 Nov; 17(7):A403. PMID: 27200969. Abstract

Factors Associated with Caregiver's Burden in Relapsing-Remitting Multiple Sclerosis and Satisfaction with Current Therapies. MS-Feeling Study.

Balaña M, Fabregas M, Meca-Lallana J, Mendibe M, Garcia E

Value Health. 2014 Nov; 17(7):A402. PMID: 27200963. Abstract

Persistence in Open and Closed Data Sources: A Study of Fingolimod Verse Interferons/Glatiramer Acetate in Patients with Multiple Sclerosis.

Lahoz R, Bergvall N, Nazareth T, Korn JR

Value Health. 2014 Nov; 17(7):A401. PMID: 27200959. Abstract

Health Care Resource Use and Cost Of Multiple Sclerosis in Slovakia: Results from the National Cross-Sectional Study.

Ondrusova M, Psenkova M, Donath V

Value Health. 2014 Nov; 17(7):A396-7. PMID: 27200928. Abstract

Adoption of Oral Disease Modifying Treatments to Manage Patients with Relapsing Remitting Multiple Sclerosis from 2011-2013 in the United States.

Narayanan S, O'Meara P, White J, Chan J, Gabriele S, Hautamaki E

Value Health. 2014 Nov; 17(7):A405. PMID: 27200976. Abstract

Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies.

Smith N, Beckerman R

Value Health. 2014 Nov; 17(7):A809. PMID: 27203058. Abstract

Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis - A Case Study in Multiple Sclerosis.

Jenkins D, Czachorowski M, Bujkiewicz S, Dequen P, Jonsson P, Abrams KR

Value Health. 2014 Nov; 17(7):A576. PMID: 27201933. Abstract

Cross-disease transcriptomics: Unique IL-17A signaling in psoriasis lesions and an autoimmune PBMC signature.

Swindell WR, Sarkar MK, Liang Y, Xing X, Gudjonsson JE

J Invest Dermatol. 2016 May 17. PMID: 27206706. Abstract

Difficulties in adjustment to multiple sclerosis: vulnerability and unpredictability of illness in the foreground.

Giovannetti A M, Brambilla L, Clerici V T, Antozzi C, Mantegazza R, Černiauskaitė M, Confalonieri P

Disabil Rehabil. 2016 May 20:1-7. PMID: 27206327. Abstract

Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways.

Liu G, Zhang F, Jiang Y, Hu Y, Gong Z, Liu S, Chen X, Jiang Q, Hao J

Mult Scler. 2016 May 19. PMID: 27207450. Abstract

Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study.

Gold R, Arnold DL, Bar-Or A, Hutchinson M, Kappos L, Havrdova E, Macmanus DG, Yousry TA, Pozzilli C, Selmaj K, et al.

Mult Scler. 2016 May 19. PMID: 27207449. Abstract

Validation of White-Matter Lesion Change Detection Methods on a Novel Publicly Available MRI Image Database.

Lesjak Ž, Pernuš F, Likar B, Špiclin Ž

Neuroinformatics. 2016 May 20. PMID: 27207310. Abstract

Astrocyte tissue factor controls CNS hemostasis and autoimmune inflammation.

Wang S, Reeves B, Pawlinski R

Thromb Res. 2016 May; 141 Suppl 2:S65-7. PMID: 27207429. Abstract

Biotinidase deficiency mimicking neuromyelitis optica beginning at the age of 4: A treatable disease.

Girard B, Bonnemains C, Schmitt E, Raffo E, Bilbault C

Mult Scler. 2016 May 6. PMID: 27207447. Abstract

Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.

Otero-Romero S, Sastre-Garriga J, Comi G, Hartung H-P, Sørensen P S, Thompson AJ, Vermersch P, Gold R, Montalban X

Mult Scler. 2016 May 19. PMID: 27207462. Abstract

Determinants of High Cost in Multiple Sclerosis Patients: A Claims and Chart Review Study.

Ke X, Navaratnam P, Sasane R, Eisenberg Lawrence DF, Friedman HS, Tulsi BB, Vollmer T

Curr Med Res Opin. 2016 May 20:1-47. PMID: 27207562. Abstract

Astrocytes in multiple sclerosis.

Ludwin SK, Rao VTS, Moore CS, Antel JP

Mult Scler. 2016 Apr 19. PMID: 27207458. Abstract

Information processing speed in multiple sclerosis: Past, present, and future.

Costa SL, Genova HM, DeLuca J, Chiaravalloti ND

Mult Scler. 2016 May 9. PMID: 27207446. Abstract

Multiple sclerosis disease-modifying therapy and pregnancy.

Miller AE

Mult Scler. 2016 May; 22(6):715-6. PMID: 27207870. Abstract

Cortical functional modifications following optic neuritis.

Benoliel T, Raz N, Ben-Hur T, Levin N

Mult Scler. 2016 May 19. PMID: 27207448. Abstract

NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugs.

Sormani M P, Muraro PA, Saccardi R, Mancardi G L

Mult Scler. 2016 Apr 26. PMID: 27207454. Abstract

Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.

Bjørnevik K, Riise T, Benjaminsen E, Celius EG, Dahl OP, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr K-M, Torkildsen Ø, et al.

Mult Scler. 2016 May 5. PMID: 27207453. Abstract

Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod.

Papathemeli D, Gräfe R, Hildebrandt U, Zettl UK, Ulrich J

Mult Scler. 2016 Apr 26. PMID: 27207455. Abstract

Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study.

Petzold A, Steenwijk MD, Eikelenboom JM, Wattjes MP, Uitdehaag B M

Mult Scler. 2016 May 11. PMID: 27207456. Abstract

Boosting CNS axon regeneration by circumventing limitations of natural cytokine signaling.

Leibinger M, Andreadaki A, Gobrecht P, Levin E, Fischer D

Mol Ther. 2016 May 16. PMID: 27203446. Abstract

A triple-effect cocktail produced by neural stem cells as a novel neurorepair therapy for chronic stage CNS autoimmunity.

Li X, Zhang Y, Yan Y, Ciric B, Ma C-G, Gran B, Curtis M, Rostami AM, Zhang G-X

Mol Ther. 2016 May 16. PMID: 27203442. Abstract

Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.

Kvarta MD, Sharma D, Castellani RJ, Morales RE, Reich SG, Kimball AS, Shin RK

BMC Neurol. 2016; 16(1):72. Epub 2016 May 21. PMID: 27206499. Abstract

Evaluation of chronic inflammatory demyelinating polyneuropathy: 3D nerve-sheath signal increased with inked rest-tissue rapid acquisition of relaxation enhancement imaging (3D SHINKEI).

Hiwatashi A, Togao O, Yamashita K, Kikuchi K, Ogata H, Yamasaki R, Yoneyama M, Kira J-I, Honda H

Eur Radiol. 2016 May 21. Epub 2016 May 21. PMID: 27208993. Abstract

Letter to the Editor: Trigeminal neuralgia in patients with multiple sclerosis.

Salma A, Alkhani A, Akil H

J Neurosurg. 2016 May 20:1-2. PMID: 27203144. Abstract

Manual Segmentation of MS Cortical Lesions Using MRI: A Comparison of 3 MRI Reading Protocols.

Maranzano J, Rudko DA, Arnold DL, Narayanan S

AJNR Am J Neuroradiol. 2016 May 19. PMID: 27197988. Abstract

Gut environment-induced intraepithelial autoreactive CD4(+) T cells suppress central nervous system autoimmunity via LAG-3.

Kadowaki A, Miyake S, Saga R, Chiba A, Mochizuki H, Yamamura T

Nat Commun. 2016; 7:11639. PMID: 27198196. Abstract

Regional Frontal Perfusion Deficits in Relapsing-Remitting Multiple Sclerosis with Cognitive Decline.

Vitorino R, Hojjat S-P, Cantrell CG, Feinstein A, Zhang L, Lee L, O'Connor P, Carroll TJ, Aviv RI

AJNR Am J Neuroradiol. 2016 May 19. PMID: 27197989. Abstract

Cryopreserved vitamin D3-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients.

Mansilla M J, Contreras-Cardone R, Navarro-Barriuso J, Cools N, Berneman Z, Ramo-Tello C, Martínez-Cáceres E M

J Neuroinflammation. 2016; 13(1):113. Epub 2016 May 20. PMID: 27207486. Abstract

Astrocytic IL-6 Influences the Clinical Symptoms of EAE in Mice.

Erta M, Giralt M, Jiménez S, Molinero A, Comes G, Hidalgo J

Brain Sci. 2016; 6(2). PMID: 27196935. Abstract

Clinical utility and psychometric properties of the Functional Assessment of Multiple Sclerosis for individuals with multiple sclerosis.

Smith EL, Driskell LD

Rehabil Psychol. 2016 May; 61(2):218-9. PMID: 27196864. Abstract

Estrogens, Neuroinflammation and Neurodegeneration.

Villa A, Vegeto E, Poletti A, Maggi A

Endocr Rev. 2016 May 19:er20161007. PMID: 27196727. Abstract

Evaluation of quality of life in individuals with severe chronic motor disability: A major challenge.

Rousseau M-C, Baumstarck K, Billette de Villemeur T, Auquier P

Intractable Rare Dis Res. 2016 May; 5(2):83-9. PMID: 27195190. Abstract

Myelin Sheath Development in the Maxillary Nerve of the Newborn Pig.

Papageorgiou KV, Grivas I, Chiotelli M, Panteris E, Papaioannou N, Nauwynck H, Kritas SK

Anat Histol Embryol. 2016 May 19. PMID: 27194445. Abstract

Multiple sclerosis: Real-world long-term benefits of disease-modifying MS therapy.

Fyfe I

Nat Rev Neurol. 2016 Jul; 12(7):372. Epub 2016 May 20. PMID: 27197579. Abstract

Static posturography across the EDSS scale in people with multiple sclerosis: a cross sectional study.

Kalron A, Nitzani D, Achiron A

BMC Neurol. 2016; 16(1):70. Epub 2016 May 20. PMID: 27206921. Abstract

Understanding walking activity in multiple sclerosis: step count, walking intensity and uninterrupted walking activity duration related to degree of disability.

Neven A, Vanderstraeten A, Janssens D, Wets G, Feys P

Neurol Sci. 2016 May 20. Epub 2016 May 20. PMID: 27207680. Abstract

A prospective study of magnetic resonance imaging patterns of central nervous system infections in pediatric age group and young adults and their clinico-biochemical correlation.

Gupta K, Banerjee A, Saggar K, Ahluwalia A, Saggar K

J Pediatr Neurosci. 2016 Jan-Mar; 11(1):46-51. PMID: 27195033. Abstract

Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.

Sadovnick DA, Traboulsee AL, Bernales CQ, Ross JP, Forwell AL, Yee IM, Guillot-Noel L, Fontaine B, Cournu-Rebeix I, Alcina A, et al.

G3 (Bethesda). 2016 May 18. PMID: 27194806. Abstract

The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.

Dackovic J, Pekmezovic T, Mesaros S, Dujmovic I, Stojsavljevic N, Martinovic V, Drulovic J

Neurol Sci. 2016 May 20. Epub 2016 May 20. PMID: 27207679. Abstract

Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus.

Werner MH, Huang D

J Neurovirol. 2016 May 19. Epub 2016 May 19. PMID: 27198748. Abstract

Is Poor Sleep Quality Associated With Greater Disability in Patients With Multiple Sclerosis?

Vitkova M, Gdovinova Z, Rosenberger J, Szilasiova J, Mikula P, Stewart RE, Groothoff JW, van Dijk JP

Behav Sleep Med. 2016 May 18:1-11. PMID: 27191379. Abstract

Loss of Transient Receptor Potential Ankyrin 1 Channel Deregulates Emotion, Learning and Memory, Cognition, and Social Behavior in Mice.

Lee K-I, Lin H-C, Lee H-T, Tsai F-C, Lee T-S

Mol Neurobiol. 2016 May 19. Epub 2016 May 19. PMID: 27194300. Abstract

Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.

Zhang Q, Vignali DAA

Immunity. 2016 May 17; 44(5):1034-51. PMID: 27192568. Abstract

Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis?

Giffroy X, Maes N, Albert A, Maquet P, Crielaard J-M, Dive D

Acta Neurol Belg. 2016 May 19. Epub 2016 May 19. PMID: 27194163. Abstract

Vitamin D and autoimmunity.

Rosen Y, Daich J, Soliman I, Brathwaite E, Shoenfeld Y

Scand J Rheumatol. 2016 May 18:1-9. PMID: 27191042. Abstract

Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.

Doronin VB, Parkhomenko TA, Castellazzi M, Cesnik E, Buneva VN, Granieri E, Nevinsky GA

PLoS One. 2016; 11(5):e0154688. Epub 2016 May 19. PMID: 27196086. Abstract

Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.

Card TR, Langan SM, Chu TPC

Dig Dis Sci. 2016 May 19. Epub 2016 May 19. PMID: 27193564. Abstract

Further Understanding of the Immunopathology of Multiple Sclerosis: Impact on Future Treatments.

Bhise V, Dhib-Jalbut S

Expert Rev Clin Immunol. 2016 May 18. PMID: 27191526. Abstract

The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.

Lu M-C, Ji J-A, Jiang Z-Y, You Q-D

Med Res Rev. 2016 May 18. PMID: 27192495. Abstract

MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.

Severin ME, Lee PW, Liu Y, Selhorst AJ, Gormley MG, Pei W, Yang Y, Guerau-de-Arellano M, Racke MK, Lovett-Racke AE

Brain. 2016 Apr 28. PMID: 27190026. Abstract

Long-term disability and prognostic factors in polyneuropathy associated with anti-myelin- associated glycoprotein (MAG) antibodies.

Galassi G, Tondelli M, Ariatti A, Benuzzi F, Nichelli P, Valzania F

Int J Neurosci. 2016 May 17:1-25. PMID: 27188752. Abstract

Association between the IL7R T244I polymorphism and multiple sclerosis risk: a meta analysis.

Wu S, Liu Q, Zhu J-M, Wang M-R, Li J, Sun M-G

Neurol Sci. 2016 May 17. PMID: 27188999. Abstract

Translational challenge models in support of efficacy studies: Neurobehavioral and cognitive changes induced by Transcranial Magnetic Stimulation in healthy volunteers.

Martin-Trias P, Bragulat V, Peña-Gómez C, Sala-Llonch R, Lanteaume L, Cassé-Perrot C, Blin O, Micallef J, Auffret A, Bartrés-Faz D

CNS Neurol Disord Drug Targets. 2016 May 18. PMID: 27189466. Abstract

Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells.

Göbel K, Pankratz S, Asaridou C-M, Herrmann AM, Bittner S, Merker M, Ruck T, Glumm S, Langhauser F, Kraft P, et al.

Nat Commun. 2016; 7:11626. PMID: 27188843. Abstract

Relapse frequency in transitioning from natalizumab to dimethyl fumarate: assessment of risk factors.

Zurawski J, Flinn A, Sklover L, Sloane JA

J Neurol. 2016 May 18. Epub 2016 May 18. PMID: 27193310. Abstract

Optic neuritis as a presenting symptom of Mycoplasma pneumoniae infection.

Özkale Y, Erol I, Çoban-Karataş M, Alkan Ö

Turk J Pediatr. 2015 Jul-Aug; 57(4):401-406. PMID: 27186706. Abstract

Construct Validity of the Four Square Step Test in Multiple Sclerosis.

Kalron A, Givon U

Arch Phys Med Rehabil. 2016 May 12. PMID: 27181182. Abstract

Efficacy of hematopoietic stem cell formultiple sclerosis, an evidence based meta-analysis.

Li C, Feng J, Chen S, He Y

Cell Mol Biol (Noisy-le-grand). 2016; 62(4):48-52. PMID: 27188734. Abstract

Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells.

Ronchi F, Basso C, Preite S, Reboldi A, Baumjohann D, Perlini L, Lanzavecchia A, Sallusto F

Nat Commun. 2016; 7:11541. PMID: 27189410. Abstract

Biochemical manifestations of the nervous tissue degradation after the blood-brain barrier opening or water intoxication in rats.

Kozler P, Sobek O, Pokorny J

Neuro Endocrinol Lett. 2016 May 15; 37(2):114-120. PMID: 27179573. Abstract

Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.

Marignier R, Ruiz A, Cavagna S, Nicole A, Watrin C, Touret M, Parrot S, Malleret G, Peyron C, Benetollo C, et al.

J Neuroinflammation. 2016; 13(1):111. Epub 2016 May 18. PMID: 27193196. Abstract

Lithium accelerates functional motor recovery by improving remyelination of regenerating axons following ventral root avulsion and reimplantation.

Fang X-Y, Zhang W-M, Zhang C-F, Wong W-M, Li W, Wu W, Lin J-H

Neuroscience. 2016 May 13. PMID: 27185485. Abstract

Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy.

Grace PM, Loram LC, Christianson JP, Strand KA, Flyer-Adams JG, Penzkover KR, Forsayeth JR, van Dam A-M, Mahoney MJ, Maier SF, et al.

Brain Behav Immun. 2016 May 14. PMID: 27189037. Abstract

Changes in levels of oxidative stress markers and some neuronal enzyme activities in cerebrospinal fluid of multiple sclerosis patients.

Bartova R, Petrlenicova D, Oresanska K, Prochazkova L, Liska B, Turecky L, Durfinova M

Neuro Endocrinol Lett. 2016 May 15; 37(2):102-106. PMID: 27179571. Abstract

High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7T.

Betts MJ, Acosta-Cabronero J, Cardenas-Blanco A, Nestor PJ, Düzel E

Neuroimage. 2016 May 12. PMID: 27181761. Abstract

Preferential Use of Public TCR during Autoimmune Encephalomyelitis.

Zhao Y, Nguyen P, Ma J, Wu T, Jones LL, Pei D, Cheng C, Geiger TL

J Immunol. 2016 May 11. PMID: 27183575. Abstract

Pediatric Lyme Neuroborreliosis: Different clinical presentations of the same agent; Single center experience.

Celik T, Celik U, Kömür M, Tolunay O, Yildizdas R D, Yagci-Kupeli B, Kücük F, Eroglu İ

Neuro Endocrinol Lett. 2016 May 15; 37(2):107-113. PMID: 27179572. Abstract

The effectiveness of a self-management occupational therapy intervention on activity performance in individuals with multiple sclerosis-related fatigue: a randomized-controlled trial.

Kos D, Duportail M, Meirte J, Meeus M, D'hooghe MB, Nagels G, Willekens B, Meurrens T, Ilsbroukx S, Nijs J

Int J Rehabil Res. 2016 May 13. PMID: 27182847. Abstract

Tbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology.

Brucklacher-Waldert V, Ferreira C, Innocentin S, Kamdar S, Withers DR, Kullberg MC, Veldhoen M

J Immunol. 2016 May 11. PMID: 27183623. Abstract

A rare case of SPG11 mutation with multiple sclerosis.

Laurencin C, Rascle L, Cotton F, Grosset-Janin C, Bernard E, Depienne C, Vukusic S, Thobois S

Rev Neurol (Paris). 2016 May 11. PMID: 27180005. Abstract

The enigma of ceramide synthase regulation in mammalian cells.

Wegner M-S, Schiffmann S, Parnham M J, Geisslinger G, Grösch S

Prog Lipid Res. 2016 May 13; 63:93-119. PMID: 27180613. Abstract

JC Polyomavirus Abundance and Distribution in Progressive Multifocal Leukoencephalopathy (PML) Brain Tissue Implicates Myelin Sheath in Intracerebral Dissemination of Infection.

Wharton KA, Quigley C, Themeles M, Dunstan RW, Doyle K, Cahir-McFarland E, Wei J, Buko A, Reid CE, Sun C, et al.

PLoS One. 2016; 11(5):e0155897. Epub 2016 May 18. PMID: 27191595. Abstract

Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis.

Huarte E, Jun S, Rynda-Apple A, Golden S, Jackiw L, Hoffman C, Maddaloni M, Pascual DW

J Immunol. 2016 Jun 15; 196(12):5036-46. Epub 2016 May 18. PMID: 27194787. Abstract

25 Hydroxyvitamin D and Cytokines in Multiple Sclerosis.

Slavov G S, Manova MG, Trenova AG, Kostadinova II, Pavlov PI, Mateva NG, Zahariev ZI

Folia Med (Plovdiv). 2016 Jul-Sep; 57(3):200-6. PMID: 27180346. Abstract

ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.

Aggelakopoulou M, Kourepini E, Paschalidis N, Panoutsakopoulou V

J Immunol. 2016 May 13. PMID: 27183630. Abstract

[The biological role of sulfatides].

Suchański J, Ugorski M

Postepy Hig Med Dosw (Online). 2016; 70:489-504. PMID: 27180966. Abstract

Farming, Foreign Holidays, and Vitamin D in Orkney.

Weiss E, Zgaga L, Read S, Wild S, Dunlop MG, Campbell H, McQuillan R, Wilson JF

PLoS One. 2016; 11(5):e0155633. Epub 2016 May 17. PMID: 27187691. Abstract

Sunshine, Sea, and Season of Birth: MS Incidence in Wales.

Balbuena LD, Middleton RM, Tuite-Dalton K, Pouliou T, Williams K E, Noble GJ

PLoS One. 2016; 11(5):e0155181. Epub 2016 May 16. PMID: 27182982. Abstract

Normative Values for Intertrial Variability of Motor Responses to Nerve Root and Transcranial Stimulation: A Condition for Follow-Up Studies in Individual Subjects.

Troni W, Melillo F, Bertolotto A, Malucchi S, Capobianco M, Sperli F, di Sapio A

PLoS One. 2016; 11(5):e0155268. Epub 2016 May 16. PMID: 27182973. Abstract

Protective Effects of PGC-1α via the Mitochondrial Pathway in Rat Brains after Intracerebral Hemorrhage.

You Y, Hou Y, Zhai X, Li Z, Li L, Zhao Y, Zhao J

Brain Res. 2016 May 10. PMID: 27178364. Abstract

Histopathological comparison of Kearns-Sayre syndrome and PGC-1α-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy.

Szalardy L, Molnar M, Torok R, Zadori D, Vecsei L, Klivenyi P, Liberski P, Kovacs GG

Folia Neuropathol. 2016; 54(1):9-22. PMID: 27179217. Abstract

High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases.

Rocha DN, Carvalho ED, Pêgo A P

Drug Discov Today. 2016 May 10. PMID: 27178019. Abstract

Pregnancy outcomes in Lebanese women with multiple sclerosis (the LeMS study): a prospective multicentre study.

Fares J, Nassar AH, Gebeily S, Kobeissy F, Fares Y

BMJ Open. 2016; 6(5):e011210. PMID: 27178979. Abstract

Minimally Invasive En Bloc Resection of Massive Obstructive Atrial Tumour.

Cote CL, Alkhamees N, Goldbach M, Bagur R, Chu MWA

Can J Cardiol. 2016 Feb 13. PMID: 27177837. Abstract

Chronic pain disrupts the reward circuitry in multiple sclerosis.

Seixas D, Palace J, Tracey I

Eur J Neurosci. 2016 May 14. PMID: 27178661. Abstract

Anti-myelin Oligodendrocyte Glycoprotein Antibodies in a Patient with Recurrent Optic Neuritis Involving the Cerebral White Matter and Brainstem.

Adachi T, Yasui K, Takahashi T, Fujihara K, Watanabe Y, Nakashima K

Intern Med. 2016; 55(10):1351-4. Epub 2016 May 15. PMID: 27181546. Abstract

The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis.

Brandt-Wouters E, Gerlach OHH, Hupperts RMM

Int J Gynaecol Obstet. 2016 Apr 18. PMID: 27177509. Abstract

Analysis of MMP2-1306C/T and TIMP2G-418C polymorphisms with relapsing remitting multiple sclerosis.

Aksoy D, Ateş Ö, Kurt S, Çevik B, Sümbül O

J Investig Med. 2016 May 12. PMID: 27174941. Abstract

Case Report of Lewis and Sumner Syndrome with Bilateral Vagus Nerves Paralysis for 16 Years.

Vasaghi A, Ashraf A, Shirzadi A, Petramfar P

Am J Phys Med Rehabil. 2016 May 12. PMID: 27175564. Abstract

ANNALS EXPRESS: Multiple Sclerosis: Assay of Free Immunoglobulin Light Chains.

Ramsden D B

Ann Clin Biochem. 2016 May 11. PMID: 27170023. Abstract

A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone.

Javidi S, Razavi B M, Hosseinzadeh H

Phytother Res. 2016 May 11. PMID: 27169925. Abstract

Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls.

Brenner P, Mittendorfer-Rutz E, Jokinen J, Alexanderson K, Hillert J, Tinghög P

Soc Psychiatry Psychiatr Epidemiol. 2016 May 11. PMID: 27169415. Abstract

A survey of endogenous retrovirus (ERV) sequences in the vicinity of multiple sclerosis (MS)-associated single nucleotide polymorphisms (SNPs).

Brütting C, Emmer A, Kornhuber M, Staege MS

Mol Biol Rep. 2016 May 12. PMID: 27169423. Abstract

The association of IL-18 gene promoter polymorphisms and the levels of serum IL-18 on the risk of multiple sclerosis.

Orhan G, Eruyar E, Mungan S Ö, Ak F, Karahalil B

Clin Neurol Neurosurg. 2016 May 3; 146:96-101. PMID: 27177146. Abstract

Glial progenitor cell-based treatment of the childhood leukodystrophies.

Osorio JM, Goldman SA

Exp Neurol. 2016 May 8. PMID: 27170209. Abstract

Caveolin-1 Is Critical for Lymphocyte Trafficking into Central Nervous System during Experimental Autoimmune Encephalomyelitis.

Wu H, Deng R, Chen X, Wong W C, Chen H, Gao L, Nie Y, Wu W, Shen J

J Neurosci. 2016 May 11; 36(19):5193-9. PMID: 27170118. Abstract

Regression-Based Norms for the Brief Visuospatial Memory Test-Revised in Italian population and application in MS patients.

Argento O, Smerbeck A, Pisani V, Magistrale G, Incerti CC, Caltagirone C, Benedict RHB, Nocentini U

Clin Neuropsychol. 2016 May 13:1-10. PMID: 27174449. Abstract

Malignancies after mitoxantrone for multiple sclerosis: A retrospective cohort study.

Buttmann M, Seuffert L, Mäder U, Toyka KV

Neurology. 2016 May 11. PMID: 27170571. Abstract

Host cell virus entry mechanisms enhance anti-JCV-antibody switch in natalizumab-treated multiple sclerosis patients.

Achiron A, Miron G, Zilkha-Falb R, Magalashvili D, Dolev M, Stern Y, Gurevich M

J Neurovirol. 2016 May 11. PMID: 27170332. Abstract

MRI monitoring of spinal cord changes in patients with multiple sclerosis.

Rovira A, De Stefano N

Curr Opin Neurol. 2016 May 12. PMID: 27175890. Abstract

Peripheral neuropathy occurring soon after cord blood transplantation.

Harada S, Hayashi H, Tadera N, Iwama K, Kajiwara K, Kouzai Y, Koudo H

Rinsho Ketsueki. 2016 Apr; 57(4):472-6. PMID: 27169453. Abstract

The relationship between static posturography measures and specific cognitive domains in individuals with multiple sclerosis.

Kalron A

Int J Rehabil Res. 2016 May 11. PMID: 27171608. Abstract

Mucocele After Orbital Fracture Repair Masquerading as Optic Neuritis.

Park J, Kim J, Choi J, Kim H

J Craniofac Surg. 2016 May 11. PMID: 27171955. Abstract

Gut microbiota in early pediatric multiple sclerosis: a case-control study.

Tremlett H, Fadrosh DW, Faruqi AA, Zhu F, Hart J, Roalstad S, Graves J, Lynch S, Waubant E, US Network of Pediatric MS Centers

Eur J Neurol. 2016 May 13. PMID: 27176462. Abstract

Exploring Concordance of Patient-Reported Information on PatientsLikeMe and Medical Claims Data at the Patient Level.

Eichler GS, Cochin E, Han J, Hu S, Vaughan TE, Wicks P, Barr C, Devenport J

J Med Internet Res. 2016; 18(5):e110. PMID: 27174602. Abstract

Hippocampal expressions of metallothionein I/II and glycoprotein 96 in EAE-prone and EAE-resistant strains of rats.

Kezele T G, Zagorac G B, Jakovac H, Domitrovic R, Radosevic-Stasic B

Histol Histopathol. 2016 May 13:11780. PMID: 27173051. Abstract

Transcriptome Analysis of Peripheral Blood in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients Identifies TNFR1 and TLR Pathways in the IVIg Response.

Richard A, Corvol J-C, Debs R, Reach P, Tahiri K, Carpentier W, Gueguen J, Guillemot V, Labeyrie C, Adams D, et al.

Medicine (Baltimore). 2016 May; 95(19):e3370. PMID: 27175635. Abstract

Pediatric Optic Neuritis Prospective Outcomes Study.

Pineles SL, Liu GT, Waldman AT, Lazar E, Kupersmith MJ, Repka MX, Pediatric Eye Disease Investigator Group and the Neuro-Ophthalmology Research Disease Investigator Consortium

J Neuroophthalmol. 2016 Jun; 36(2):115-7. PMID: 27176554. Abstract

Intraventricular injections of mesenchymal stem cells activate endogenous functional remyelination in a chronic demyelinating murine model.

Cruz-Martinez P, González-Granero S, Molina-Navarro MM, Pacheco-Torres J, García-Verdugo JM, Geijo-Barrientos E, Jones J, Martinez S

Cell Death Dis. 2016; 7:e2223. PMID: 27171265. Abstract

The Association Between Genetic Polymorphism rs703842 in CYP27B1 and Multiple Sclerosis: A Meta-Analysis.

Jiang T, Li L, Wang Y, Zhao C, Yang J, Ma D, Guan Y, Zhao D, Bao Y, Wang Y, et al.

Medicine (Baltimore). 2016 May; 95(19):e3612. PMID: 27175669. Abstract

Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.

Schippling S, O'Connor P, Knappertz V, Pohl C, Bogumil T, Suarez G, Cook S, Filippi M, Hartung H-P, Comi G, et al.

J Neurol. 2016 May 13. Epub 2016 May 13. PMID: 27177997. Abstract

Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity.

Beer A, Biberacher V, Schmidt P, Righart R, Buck D, Berthele A, Kirschke J, Zimmer C, Hemmer B, Mühlau M

J Neurol. 2016 May 13. Epub 2016 May 13. PMID: 27178000. Abstract

Multiple sclerosis: Bigger brains resist disability in MS.

Fyfe I

Nat Rev Neurol. 2016 Jun; 12(6):312-3. Epub 2016 May 13. PMID: 27174239. Abstract

Comparison of brainstem reflex recordings and evoked potentials with clinical and MRI data to assess brainstem dysfunction in multiple sclerosis: a short-term follow-up.

Magnano I, Pes GM, Cabboi MP, Pilurzi G, Ginatempo F, Achene A, Salis A, Conti M, Deriu F

Neurol Sci. 2016 May 13. Epub 2016 May 13. PMID: 27177651. Abstract

Newly Identified Gait Patterns in Patient With Multiple Sclerosis May Be Related to Push-Off Quality.

Kempen JCE, Doorenbosch CAM, Knol DL, de Groot V, Beckerman H

Phys Ther. 2016 May 12. Epub 2016 May 12. PMID: 27174257. Abstract

MAL Is a Regulator of the Recruitment of Myelin Protein PLP to Membrane Microdomains.

Bijlard M, de Jonge JC, Klunder B, Nomden A, Hoekstra D, Baron W

PLoS One. 2016; 11(5):e0155317. Epub 2016 May 12. PMID: 27171274. Abstract

Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple Sclerosis.

Laible M, Jarius S, Mackensen F, Schmidt-Bacher A, Platten M, Haas J, Albrecht P, Wildemann B

PLoS One. 2016; 11(5):e0155322. Epub 2016 May 12. PMID: 27171375. Abstract

The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists' Perspectives.

Isaac S, Saini B, Chaar BB

PLoS One. 2016; 11(5):e0155113. Epub 2016 May 12. PMID: 27171490. Abstract

Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study.

Doring T M, Granado V, Rueda F, Deistung A, Reichenbach JR, Tukamoto G, Gasparetto E L, Schweser F

PLoS One. 2016; 11(5):e0155027. Epub 2016 May 12. PMID: 27171423. Abstract

A fatal mycotic sepsis after retrograde intrarenal surgery: a case report and literature review.

Cindolo L, Berardinelli F, Castellan P, Castellucci R, Pellegrini F, Schips L

Urologia. 2016 May 6. Epub 2016 May 06. PMID: 27174535. Abstract

Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.

Lopez de Lapuente A, Feliú A, Ugidos N, Mecha M, Mena J, Astobiza I, Riera J, Carillo-Salinas F, Comabella M, Montalban X, et al.

J Immunol. 2016 Jun 1; 196(11):4553-65. Epub 2016 May 04. PMID: 27183579. Abstract

CNS Remyelination and the Innate Immune System.

McMurran CE, Jones CA, Fitzgerald DC, Franklin RJM

Front Cell Dev Biol. 2016; 4:38. Epub 2016 May 03. PMID: 27200350. Abstract

Effects of deep heating provided by therapeutic ultrasound on demyelinating nerves.

Aydin E, Tastaban E, Omurlu I K, Turan Y, Şendur Ö F

J Phys Ther Sci. 2016 Apr; 28(4):1278-83. Epub 2016 Apr 28. PMID: 27190467. Abstract

Perspectives and experiences of Dutch multiple sclerosis patients and multiple sclerosis-specialized neurologists on injectable disease-modifying treatment.

Visser LH, Heerings MA, Jongen PJ, van der Hiele K

Patient Prefer Adherence. 2016; 10:659-67. Epub 2016 Apr 26. PMID: 27175066. Abstract

All relapsing multiple sclerosis patients should be seen in specialist clinics - NO.

Brenner R

Mult Scler. 2016 Jun; 22(7):875-6. Epub 2016 Apr 22. PMID: 27207460. Abstract

All relapsing multiple sclerosis patients should be managed at a specialist clinic - YES.

Brownlee WJ, Ciccarelli O

Mult Scler. 2016 Jun; 22(7):873-5. Epub 2016 Apr 22. PMID: 27207459. Abstract

All relapsing multiple sclerosis patients should be managed at a specialist clinic - Commentary.

Hutchinson M

Mult Scler. 2016 Jun; 22(7):876-7. Epub 2016 Apr 22. PMID: 27207461. Abstract

Co-occurrence of multiple sclerosis and Parkinson disease.

Shaygannejad V, Shirmardi M, Dehghani L, Maghzi H

Adv Biomed Res. 2016; 5:75. Epub 2016 Apr 21. PMID: 27195248. Abstract

The Efficacy of Functional Electrical Stimulation of the Abdominal Muscles in the Treatment of Chronic Constipation in Patients with Multiple Sclerosis: A Pilot Study.

Singleton C, Bakheit A M, Peace C

Mult Scler Int. 2016; 2016:4860315. Epub 2016 Apr 20. PMID: 27200190. Abstract

Unilateral Optic Neuritis: A Rare Complication after Measles-Mumps-Rubella Vaccination in a 30-Year-Old Woman.

De Giacinto C, Guaglione E, Leon PE, D'Aloisio R, Vattovani O, Ravalico G, Tognetto D

Case Rep Ophthalmol Med. 2016; 2016:8740264. Epub 2016 Apr 19. PMID: 27195163. Abstract

Leptomeningeal enhancement in Susac's syndrome and multiple sclerosis: Time to expect the unexpected?

Sastre-Garriga J

Mult Scler. 2016 Jun; 22(7):975-6. Epub 2016 Apr 18. PMID: 27207451. Abstract

Susac's syndrome: Leptomeningeal enhancement on 3D FLAIR MRI.

Engisch R, Titelbaum DS, Chilver-Stainer L, Kellner-Weldon F

Mult Scler. 2016 Jun; 22(7):972-4. Epub 2016 Apr 18. PMID: 27207452. Abstract

Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy.

Iodice R, Carotenuto A, Dubbioso R, Cerillo I, Santoro L, Manganelli F

J Neurol Sci. 2016 Jun 15; 365:143-6. Epub 2016 Apr 16. PMID: 27206893. Abstract

Icariin exerts estrogen-like activity in ameliorating EAE via mediating estrogen receptor β, modulating HPA function and glucocorticoid receptor expression.

Wei Z, Wang M, Hong M, Diao S, Liu A, Huang Y, Yu Q, Peng Z

Am J Transl Res. 2016; 8(4):1910-8. Epub 2016 Apr 15. PMID: 27186315. Abstract

Bilateral vertebral artery dissection in the setting of ADEM.

Stirn SL, Freilinger C, Roeben B, Tünnerhoff J, Berg D, Freilinger T

J Neurol Sci. 2016 Jun 15; 365:212-3. Epub 2016 Apr 13. PMID: 27206909. Abstract

Histamine and Immune Biomarkers in CNS Disorders.

Cacabelos R, Torrellas C, Fernández-Novoa L, López-Muñoz F

Mediators Inflamm. 2016; 2016:1924603. Epub 2016 Apr 13. PMID: 27190492. Abstract

Can aerobic exercise alleviate flu-like symptoms following interferon beta-1a injections in patients with multiple sclerosis?

Langeskov-Christensen M, Kjølhede T, Stenager E, Jensen H B, Dalgas U

J Neurol Sci. 2016 Jun 15; 365:114-20. Epub 2016 Apr 08. PMID: 27206886. Abstract

Olfactory dysfunction in patients with multiple sclerosis.

Li L-M, Yang L-N, Zhang L-J, Fu Y, Li T, Qi Y, Wang J, Zhang D-Q, Zhang N, Liu J, et al.

J Neurol Sci. 2016 Jun 15; 365:34-9. Epub 2016 Apr 06. PMID: 27206870. Abstract

Asymptomatic subjects differ less from their twin siblings with MS than from healthy controls in cognitive functioning. A Finnish Twin Cohort study.

Kuusisto H, Vahvelainen T, Hämäläinen P, Luukkaala T, Elovaara I

J Neurol Sci. 2016 Jun 15; 365:50-3. Epub 2016 Apr 03. PMID: 27206874. Abstract

Anti-JC virus seroprevalence in a Spanish multiple sclerosis cohort: JC virus seroprevalence in Spain.

Aladro Y, Terrero R, Cerezo M, Ginestal R, Ayuso L, Meca-Lallana V, Millán J, Borrego L, Martinez-Ginés M, Rubio L, et al.

J Neurol Sci. 2016 Jun 15; 365:16-21. Epub 2016 Apr 02. PMID: 27206867. Abstract

Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core Findings.

Antony BJ, Chen M, Carass A, Jedynak BM, Al-Louzi O, Solomon SD, Saidha S, Calabresi PA, Prince JL

Proc SPIE Int Soc Opt Eng. 2016 Feb 27; 9788. Epub 2016 Mar 29. PMID: 27199503. Abstract

Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial.

Hunter SF, Agius M, Miller DM, Cutter G, Barbato L, McCague K, Meng X, Agashivala N, Chin P, Hollander E

J Neurol Sci. 2016 Jun 15; 365:190-8. Epub 2016 Mar 22. PMID: 27206905. Abstract

Short Term Reproducibility of a High Contrast 3-D Isotropic Optic Nerve Imaging Sequence in Healthy Controls.

Harrigan RL, Smith AK, Mawn LA, Smith SA, Landman BA

Proc SPIE Int Soc Opt Eng. 2016 Feb 27; 9783. Epub 2016 Mar 22. PMID: 27175048. Abstract

Simultaneous Segmentation of Retinal Surfaces and Microcystic Macular Edema in SDOCT Volumes.

Antony BJ, Lang A, Swingle EK, Al-Louzi O, Carass A, Solomon S, Calabresi PA, Saidha S, Prince JL

Proc SPIE Int Soc Opt Eng. 2016 Feb 27; 9784. Epub 2016 Mar 21. PMID: 27199502. Abstract

Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes.

Notturno F, Kokubun N, Sekiguki Y, Nagashima T, De Lauretis A, Yuki N, Kuwabara S, Uncini A

J Neurol Sci. 2016 Jun 15; 365:132-6. Epub 2016 Feb 23. PMID: 27206890. Abstract

Transplantation of mesenchymal stem cells promotes the functional recovery of the central nervous system following cerebral ischemia by inhibiting myelin-associated inhibitor expression and neural apoptosis.

Feng N, Hao G, Yang F, Qu F, Zheng H, Liang S, Jin Y

Exp Ther Med. 2016 May; 11(5):1595-1600. Epub 2016 Feb 19. PMID: 27168778. Abstract

The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D.

Grant WB

Dermatoendocrinol. 2016 Jan-Dec; 8(1):e1137400. Epub 2016 Jan 08. PMID: 27195055. Abstract

Multidisciplinary rehabilitation and steroids in the management of multiple sclerosis relapses: a randomized controlled trial.

Nedeljkovic U, Dackovic J, Tepavcevic D K, Basuroski I D, Mesaros S, Pekmezovic T, Drulovic J

Arch Med Sci. 2016 Apr 1; 12(2):380-9. Epub 2015 Mar 18. PMID: 27186184. Abstract

Central Pontine and Extrapontine Myelinolysis in a Patient with Traumatic Brain Injury Following Not Rapid Correction of Hyponatremia: A Case Report.

Baek T H, Yang S-H, Sung J H, Lee S W

Korean J Neurotrauma. 2014 Apr; 10(1):31-4. Epub 2014 Apr 30. PMID: 27169030. Abstract

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

Papers: 16 May 2016 - 23 May 2016

MSDF Footer

Search form

Papers: 16 May 2016 - 23 May 2016